A4031212
Epoprostenol sodium , 96% , 61849-14-7
Synonym(s):
(5Z,9α,11α,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt;Epoprostenol sodium salt;PGI?, Prostacyclin;PGI2-Na;Prostacyclin sodium salt
CAS NO.：61849-14-7
Empirical Formula: C20H31NaO5
Molecular Weight: 374.45
MDL number: MFCD00135629
EINECS: 263-273-7
| Pack Size | Price | Stock | Quantity |
| 1MG | RMB799.20 | In Stock |
|
| 5mg | RMB3599.20 | In Stock |
|
| 10MG | RMB6399.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 168-170 °C |
| RTECS | UK8008700 |
| storage temp. | -20°C |
| solubility | H2O: 1 mg/mL Hydrolyzes to 6-ketoprostaglandin F1α in aqueous solution. |
| form | powder |
| color | white |
| biological source | synthetic |
| Water Solubility | Soluble to 100 mM in water |
| Sensitive | Moisture Sensitive |
| Merck | 13,7967 |
| BRN | 6472195 |
| Stability: | Light Sensitive, Temperature Sensitive |
| CAS DataBase Reference | 61849-14-7(CAS DataBase Reference) |
Description and Uses
Epoprostenol is a naturally occurring prostaglandin indicated for the preservation of platelet function during cardiopulmonary bypass, prevention of platelet aggregation during charcoal hemoperfusion of patients in hepatic failure, and as an alternative to heparin during renal dialysis.
Prostaglandin I2 sodium salt has been used:
- in the preparation of stock solution for platelet washing procedure
- as supplement in platelet-rich-plasma, for platelet preparation
- to prevent platelet activation
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302+H312+H332-H302-H312-H332 |
| Precautionary statements | P261-P280-P301+P312+P330-P280h-P301+P312a-P304+P340-P321-P501a |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22 |
| Safety Statements | 22-26-36 |
| WGK Germany | 3 |
| F | 3-10 |
| HS Code | 29329900 |
